Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staging invasive bladder tumors.

H W Herr1

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Journal of Surgical Oncology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Bladder tumor staging using T-category alone often understages disease. Palpable masses and tumor volume may improve clinical staging accuracy for better treatment planning and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique.

Transplantation proceedings·2013
Same author

Bedside sphincterometry.

Urology·2011
Same author

Selecting clinical research projects for the urologic oncologist.

Urologic oncology·2011
Same author

Uncertainty and outcome of invasive bladder tumors.

Urologic oncology·2011
Same author

Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality).

BJU international·2003
Same author

A comparison of hospital-based charges following partial and radical nephrectomy.

Urologic oncology·2002
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
Same journal

A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

Journal of surgical oncology·2026
Same journal

How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

Journal of surgical oncology·2026
Same journal

New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

Journal of surgical oncology·2026
See all related articles

Area of Science:

  • Urologic oncology
  • Cancer staging
  • Clinical diagnostics

Background:

  • Bladder tumor staging is crucial for treatment and prognosis.
  • Current clinical staging relies on tumor invasion depth (T-category).
  • T-category alone frequently understages disease and offers unreliable treatment outcome predictions.

Purpose of the Study:

  • To evaluate the prognostic value of a palpable mass on bimanual examination in bladder tumors.
  • To explore the potential of incorporating tumor volume into clinical staging.
  • To enhance the accuracy of clinical bladder cancer staging.

Main Methods:

  • Analysis of clinical data for bladder tumor staging.
  • Assessment of bimanual examination findings (palpable mass).

Related Experiment Videos

  • Correlation of tumor volume and invasion depth with clinical outcomes.

    • Main Results:

    • A palpable mass on bimanual examination demonstrated prognostic significance.
    • Tumor volume, alongside microscopic invasion, may improve staging accuracy.
    • Current T-category staging has limitations in predicting treatment response.

    Conclusions:

    • Bimanual examination findings and tumor volume are valuable additions to bladder cancer clinical staging.
    • Integrating these factors can lead to more accurate staging and improved treatment planning.
    • Further research is warranted to refine clinical staging protocols for bladder tumors.